Jeff Bird

Jeff Bird is currently a Board Member at Epirium. Jeff has previously held positions at Leyden Labs, Foresight Dx, Kriya Therapeutics, Nutcracker Therapeutics, Epirium, Bluebird Ventures, Procyrion, Inc., GRAIL, Inc., and Sutter Hill Ventures.

Jeff Bird received their MD from Stanford University School of Medicine and also has a Ph.D. in Cancer Biology from the same school. Jeff completed their undergraduate studies at Stanford University, earning a Bachelor of Science (BS) degree.